The Center for Bioethics and Social Sciences in Medicine (CBSSM) hosted a one day research colloquium on Tuesday, March 17, 2015 at the University of Michigan’s Alumni Center Founders Room. Natalie Bartnik, MPH and Michele Gornick,PhD presented new research findings from MI-ONCOSEQ study.


A new review article has been published by Dr. Scott Roberts and his colleagues. This publication discusses the emerging areas of interests in public health genomics.


UMHS Adult and Pediatric Ethics Committee and the Program of Society and Medicine is sponsoring Bioethics Grand Rounds. On Wednesday October 29, 2014, Wendy Uhlmann, M.S., CGC, will present her talk “Genetic Testing of Children for Adult-Onset Conditions: Ethical Considerations” at Ford Auditorium. The event is open to the public. For more information, please refer to the flyer here.


Michele Gornick, PhD, of the Center for Bioethics, Social Science and Medicine received a Post-doctoral Translational Scholars Award from the Michigan Institute for Clinical and Health Research (MICHR) at the University of Michigan.


On Sunday, September 28th 2014, individuals of all ages from the Ann Arbor/Ypsilanti community will unite to raise awareness and funds for Alzheimer’s care, support and research. According to the Alzheimer's Association 2014 Facts and Figures, more than 5 million Americans are living with Alzheimer's disease. We invite you to join us as we work together to fight against this devastating disease.


Dr. Scott Roberts was invited to speak at AAIC about his work investigating the psychological and behavioral impact of APOE genotype disclosure. This year the Alzheimer’s Association International Conference (AAIC) was held in Copenhagen, Denmark during July 12-17, 2014. Over 4,000 researchers from more than 60 countries attended the conference revealing the latest study results and discoveries in dementia research.


What does the public believe?

Alzheimer’s disease affects approximately 5.4 million people in the United States. Although there are no proven strategies to prevent the disease, much has been learned in recent years about possible risk and protective factors for Alzheimer’s disease beyond genetics and age. These possible factors include physical activity, diet, social connections, and environmental exposures. In their recent publication, investigators Scott Roberts, PhD, Sara McLaughlin, PhD, and Cathleen Connell, PhD conducted a study to assess public belief and knowledge about risk and protective factors for Alzheimer's disease. They found that older and middle-aged adults are interested in their Alzheimer's disease risk status and believe that steps can be taken to reduce disease risk. 


On November 19-21, 2013, the Brocher Foundation held an invitational workshop, bring together 31 leading researchers and scholars from around the world to explore the issue of feedback of incidental findings and results to research participants. At the workshop, Dr. Scott Roberts presented on "What findings should be offered to research participants whose data and specimens are archived in biobanks? 


At the conference, Dr. Roberts spoke about the ethical and practice issues involving integrating whole-genome sequencing into clinical practice.


On September 18, 2013, the Alzheimer's Prevention Initiative (API) received a NIH grant for their second trial of an anti-amyloid treatment to prevent Alzheimer’s disease.